期刊文献+

PAR-1促进肿瘤恶性行为机制的研究进展 被引量:1

下载PDF
导出
摘要 蛋白酶活化受体-1(PAR-1)是PARs家族中第一个被发现的成员,也称凝血酶受体。PAR-1被肿瘤微环境中的蛋白酶水解激活后,介导多种肿瘤细胞的生物学行为:促进肿瘤细胞增殖、黏附、迁移、侵袭,并参与肿瘤生长、血管新生等多个环节和多条通路。同时,通过调控下游分子和细胞因子,PAR-1可对肿瘤微环境进行重塑,促进肿瘤的进展。
出处 《细胞与分子免疫学杂志》 CAS CSCD 北大核心 2012年第3期333-335,共3页 Chinese Journal of Cellular and Molecular Immunology
基金 国家高技术研究发展计划(863)资助项目(2008AA02Z109)
  • 相关文献

参考文献21

  • 1Whitehead I,Kirk H,Kay R.Expression cloning of oncogenes by ret-roviral transfer of cDNA libraries[J].Mol Cell Biol,1995,15(2):704-710. 被引量:1
  • 2Garcia-Lopez MT,Gutierrez-Rodriguez M,Herranz R.Thrombin-acti-vated receptors:promising targets for cancer therapy?[J].Curr MedChem,2010,17(2):109-128. 被引量:1
  • 3Cohen I,Maoz M,Turm H,et al.Etk/Bmx regulates proteinase-acti-vated-receptor1(PAR1)in breast cancer invasion:signaling part-ners,hierarchy and physiological significance[J].PLoS One,2010,5(6):e11135. 被引量:1
  • 4刘星,胡煜辉,肖游章,张晓春,周青,李晓飞.PAR-2在人胰腺肿瘤细胞中的表达及其相关机制的研究[J].细胞与分子免疫学杂志,2011,27(4):430-432. 被引量:2
  • 5Elste AP,Petersen I.Expression of proteinase-activated receptor 1-4(PAR 1-4)in human cancer[J].J Mol Histol,2010,41(2-3):89-99. 被引量:1
  • 6Hernandez NA,Correa E,Avila EP,et al.PAR1 is selectively overexpressed in high grade breast cancer patients:a cohort study[J].JTransl Med,2009,7:47. 被引量:1
  • 7Zhang Y,Zhan H,Xu W,et al.Upregulation of matrix metalloprotei-nase-1 and proteinase-activated receptor-1 promotes the progression ofhuman gliomas[J].Pathol Res Pract,2011,207(1):24-29. 被引量:1
  • 8张晓飞,董琼珠,薛裕华,周海军,叶青海,任宁,贾户亮,钦伦秀.蛋白酶激活受体1在癌旁组织中的高表达与肝癌早期患者术后预后不良相关[J].中华肝脏病杂志,2011,19(4):266-270. 被引量:5
  • 9Boire A,Covic L,Agarwal A,et al.PAR1 is a matrix metallopro-tease-1 receptor that promotes invasion and tumorigenesis of breastcancer cells[J].Cell,2005,120(3):303-313. 被引量:1
  • 10Blackburn JS,Liu I,Coon CI,et al.A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma inva-sion and metastasis[J].Oncogene,2009,28(48):4237-4248. 被引量:1

二级参考文献25

  • 1窦勇鹰,谢立群,李俊美,华建平.蛋白酶激活受体的研究进展[J].世界华人消化杂志,2006,14(12):1206-1209. 被引量:5
  • 2汤钊猷.肝癌临床研究之我见[J].中华肝脏病杂志,2006,14(7):481-482. 被引量:12
  • 3Rudroff C,Seibold S,Kaufmann R,et al.Expression of the thrombin receptor PAR-1 correlates with tumor cell differentiation of pancreatic adenocarcinoma in vitro[J].Clin Exp Metastasis,2002,19(2):181-189. 被引量:1
  • 4Kawabata A,Kawao N.Physiology and pathophysiology of proteinaseactivated receptors(PARs):PARs in the respiratory system:cellular signaling and physiological/pathological roles[J].J Pharmacol Sci.2005 Jan; 97(1):20-24. 被引量:1
  • 5Kawabata A.PAR-2:structure,function and relevance to human diseases of the gastric mucosa[J].Expert Rev Mol Med,2002,4(16):1-17. 被引量:1
  • 6Cottrell GS,Amadesi S,Schmidlin F,et al.Protcese-activated receptor 2:activation,signalling and function[J].Biochem Soc Trans,2003,31:1191-1197. 被引量:1
  • 7Kawabata A,Nishikawa H,Kuroda R,et al.Proteinase-activated receptor-2(PAR-2):regulation of salivary and pancreatic exocrine secretion in vivo in rats and mice[J].Br J Pharmacol,2000,129:1808-1814. 被引量:1
  • 8Kawabata A,Kuroda R,Nishida M,et al.Protease-activated receptor-2(PAR-2)in the pancreas and parotid gland:Immunolocalization and involvement of nitric oxide in the evoked amylase secretion[J].Life Sci,2002,71:2435-2446. 被引量:1
  • 9Nguyen TD,Moody MW,Steinhoff M,et al.Trypsin activates pancreatic duct epithelial cell ion channels through proteinase-activated receptor-2[J].J Clin Invest,1999,103:261-269. 被引量:1
  • 10Xue YH,Zhang XF,Dong QZ,et al.Thrombin is a therapeutic target for metastatic osteopontin-positive hepatocellular carcinoma.Hepatology,2010,52:2012-2022. 被引量:1

共引文献5

同被引文献14

引证文献1

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部